Free release
4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morphol

4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morphol

CAS No. :700874-71-1MDL No. :MFCD12923354Formula :C26H27N5O2Boiling Point :-Linear Structure Formula :-InChI Key :IHLVSL

Sales:Service@apichina.com
CAS No. :700874-71-1 Brand :Qitai
Formula :C26H27N5O2 M.W :441.52

Introduction

CAS No. :700874-71-1 MDL No. :MFCD12923354
Formula : C26H27N5O2 Boiling Point : -
Linear Structure Formula :- InChI Key :IHLVSLOZUHKNMQ-UHFFFAOYSA-N
M.W : 441.52 Pubchem ID :11655119
Synonyms :
Chemical Name :4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine

Physicochemical Properties

Num. heavy atoms : 33
Num. arom. heavy atoms : 21
Fraction Csp3 : 0.35
Num. rotatable bonds : 6
Num. H-bond acceptors : 6.0
Num. H-bond donors : 0.0
Molar Refractivity : 131.42
TPSA : 65.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.01
Log Po/w (XLOGP3) : 2.75
Log Po/w (WLOGP) : 3.44
Log Po/w (MLOGP) : 1.54
Log Po/w (SILICOS-IT) : 4.14
Consensus Log Po/w : 3.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.38
Solubility : 0.0182 mg/ml ; 0.0000412 mol/l
Class : Moderately soluble
Log S (Ali) : -3.78
Solubility : 0.0739 mg/ml ; 0.000167 mol/l
Class : Soluble
Log S (SILICOS-IT) : -7.82
Solubility : 0.00000662 mg/ml ; 0.000000015 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.71
Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram: